We are live on
!
Find out more
AAM
AR Asset Management Portfolio holdings
AUM
$546M
Turnover
5.65%
1-Year Est. Return
24.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.7%
1 Year Est. Return
+24.08%
3 Year Est. Return
+64.88%
5 Year Est. Return
+92.85%
10 Year Est. Return
+260.28%
AUM
$373M
AUM Growth
+$1.15M
(+0.31%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
41.32%
Holding
114
New
2
Increased
3
Reduced
9
Closed
4
Avg Time Held
7.4
years
Top 10 Avg Time Held
6.1
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$636K |
| 2 |
Bank of Hawaii
BOH
|
+$496K |
| 3 |
Baxter International
BAX
|
+$201K |
| 4 |
Target
TGT
|
+$172K |
| 5 |
Walt Disney
DIS
|
+$29.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$5.41M |
| 2 |
Apple
AAPL
|
+$3.5M |
| 3 |
Organon & Co
OGN
|
+$2.59M |
| 4 |
FRC
First Republic Bank
FRC
|
+$626K |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$444K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 21.79% |
| 2 | Technology | 19.23% |
| 3 | Healthcare | 13.54% |
| 4 | Financials | 12.06% |
| 5 | Energy | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$5.01T
| $52.1M | 13.98% |
268,633
-20,110
| -7% | -$3.5M |
2013 Q2
40 quarters
|
|
2
Chevron
CVX
$436B
| $17.9M | 4.8% |
113,636
-1,500
| -1% | -$240K |
2013 Q2
40 quarters
|
|
3
Merck
MRK
$364B
| $15.5M | 4.17% |
134,570
| – | – |
2013 Q2
40 quarters
|
|
4
Procter & Gamble
PG
$364B
| $11.4M | 3.06% |
75,109
| – | – |
2013 Q2
40 quarters
|
|
5
Philip Morris
PM
$320B
| $11M | 2.95% |
112,506
| – | – |
2013 Q2
40 quarters
|
|
6
Coca-Cola
KO
$395B
| $10.3M | 2.78% |
171,780
-100
| -0.1% | -$6.22K |
2013 Q2
40 quarters
|
|
7
JPMorgan Chase
JPM
$890B
| $9.49M | 2.55% |
65,231
-2,200
| -3% | -$303K |
2013 Q2
40 quarters
|
|
8
Berkshire Hathaway Class A
BRK.A
$1.13T
| $9.32M | 2.5% |
18
| – | – |
2013 Q2
40 quarters
|
|
9
Nike
NKE
$52.4B
| $8.67M | 2.33% |
78,570
| – | – |
2013 Q2
40 quarters
|
|
10
Microsoft
MSFT
$3.96T
| $8.27M | 2.22% |
24,279
| – | – |
2013 Q2
40 quarters
|
|
11
Alphabet (Google) Class C
GOOG
$4.2T
| $7.93M | 2.13% |
65,540
| – | – |
2016 Q2
28 quarters
|
|
12
Diageo
DEO
$51.2B
| $7.81M | 2.1% |
45,040
| – | – |
2013 Q2
40 quarters
|
|
13
PepsiCo
PEP
$176B
| $7.78M | 2.09% |
42,009
| – | – |
2013 Q2
40 quarters
|
|
|
14
Target
TGT
$70.6B
| $7.51M | 2.01% |
56,915
+1,160
| +2% | +$172K |
2013 Q2
40 quarters
|
|
15
Iron Mountain
IRM
$33B
| $7.48M | 2.01% |
131,600
| – | – |
2020 Q1
13 quarters
|
|
16
Berkshire Hathaway Class B
BRK.B
$1.13T
| $7M | 1.88% |
20,518
| – | – |
2013 Q2
40 quarters
|
|
17
Johnson & Johnson
JNJ
$612B
| $6.76M | 1.81% |
40,815
| – | – |
2013 Q2
40 quarters
|
|
18
Home Depot
HD
$295B
| $6.07M | 1.63% |
19,550
| – | – |
2013 Q2
40 quarters
|
|
19
AbbVie
ABBV
$501B
| $5.86M | 1.57% |
43,500
| – | – |
2013 Q2
40 quarters
|
|
20
Zoetis
ZTS
$31.1B
| $5.84M | 1.57% |
33,900
| – | – |
2013 Q2
40 quarters
|
|
21
Tanger
SKT
$3.94B
| $5.26M | 1.41% |
238,150
| – | – |
2013 Q2
40 quarters
|
|
22
Pfizer
PFE
$166B
| $5.19M | 1.39% |
141,575
| – | – |
2013 Q2
40 quarters
|
|
|
23
Walt Disney
DIS
$188B
| $4.85M | 1.3% |
54,290
+315
| +0.6% | +$29.8K |
2013 Q2
40 quarters
|
|
24
Altria Group
MO
$122B
| $4.69M | 1.26% |
103,626
| – | – |
2013 Q2
40 quarters
|
|
25
Loews
L
$22.3B
| $4.63M | 1.24% |
77,917
| – | – |
2013 Q2
40 quarters
|
|
Similar funds
QAM
LF
SCM
TGAM
HW
UFF
DBG
TI
AR Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, AR Asset Management held 114 positions worth $373M, up 0.31% from $372M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
AR Asset Management withdrew a net $11.9M in Q2 2023, closing 4 positions and reducing 9 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $5.41M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, AR Asset Management opened a new position in UnitedHealth worth $625K.
- AR Asset Management's largest Q2 2023 buy was UnitedHealth: 1,300 shares worth $625K.
- AR Asset Management added most to Bank of Hawaii in Q2 2023, an estimated $496K increase.
- AR Asset Management's biggest Q2 2023 reduction was Apple, cutting an estimated $3.5M.
- AR Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $5.41M.
- AR Asset Management's ten largest holdings make up 41% of its $373M portfolio in Q2 2023.
- AR Asset Management opened 2 new positions and closed 4 in Q2 2023.
- AR Asset Management's portfolio value rose 0.31% quarter-over-quarter to $373M.
Based on AR Asset Management's 13F filing for Q2 2023, filed 8 Aug 2023.